7 documents found, page 1 of 1
Adiponectin levels and sleep deprivation in patients with endocrine metabolic d...
Oliveira,Roseane Feitosa de; Daniele,Thiago Medeiros da Costa; Façanha,Cristina Figueiredo Sampaio; Forti,Adriana Costa eSUMMARY BACKGROUND: Sleep abnormalities are frequent in patients with endocrine metabolic disorders (EMD) such as arterial hypertension, diabetes and obesity. Adiponectin is a peptide largely secreted by adipocytes and has various properties e.g. anti-inflammatory, antioxidant, antiatherogenic, pro-angiogenic, vasoprotective and insulin-sensitizing. Adiponectin inversely relates to body weight and when its conc...
Wake-up stroke: Clinical characteristics, sedentary lifestyle, and daytime slee...
Diniz,Deborath Lucia de Oliveira; Barreto,Pedro Rodrigues; Bruin,Pedro Felipe Carvalhedo de; Bruin,Veralice Meireles Sales deSummary Objective: Wake-up stroke (WUS) is defined when the exact time of the beginning of the symptoms cannot be determined, for the deficits are perceived upon awakening. Sleep alterations are important risk factors for stroke and cardiovascular diseases. This study evaluates the characteristics of patients with and without WUS, the presence of daytime sleepiness, and associated risk factors. Method: Patients...
Night eating syndrome: How to treat it?
Pinto,Thisciane Ferreira; Silva,Francisco Girleudo Coutinho da; Bruin,Veralice Meireles Sales de; Bruin,Pedro Felipe Carvalhedo deSummary Night eating syndrome (NES) is characterized by caloric intake ≥ 25% of total daily after dinner and/or by two or more weekly nocturnal awakenings accompanied by food ingestion. Causes of NES are not entirely clear and seem to involve a desynchronization between the circadian rhythms of food ingestion and sleep, resulting in a delayed pattern of food intake. Estimates of the prevalence of NES in the gen...
Neck circumference, a bedside clinical feature related to mortality of acute is...
Medeiros,Camila Andrade Mendes; Bruin,Veralice Meireles Sales de; Castro-Silva,Claudia de; Araújo,Sonia Maria Holanda Almeida; Chaves Junior,Cauby MaiaOBJECTIVE: The aim of this study was to evaluate clinical/demographic factors, sleep alterations and one year mortality in acute ischemic stroke. METHODS: This was a prospective study of 89 consecutive patients (mean age 64.39 ± 8.51 years) with acute ischemic stroke. High risk of obstructive sleep apnea (OSA) was evaluated by the Berlin questionnaire, daytime somnolence by the Epworth Sleepiness Scale (> 10) a...
Alterações cognitivas na SAOS
Bruin,Pedro Felipe Carvalhedo de; Bagnato,Mauricio da CunhaAlterações da cognição e do desempenho estão bem estabelecidas em pacientes com SAOS, causando um impacto significativo sobre a qualidade de vida e o risco de acidentes nesses indivíduos. Tais alterações são mais profundas nos quadros mais graves de SAOS, o que explica a aparente discrepância na frequência e gravidade desse prejuízo entre estudos com pacientes de clínicas de sono e estudos de base populacional....
Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift
Bastos,João Paulo Catunda; Sousa,Romualdo Barroso de; Nepomuceno,Lara Albuquerque de Medeiros; Gutierrez-Adrianzen,Oswaldo A.OBJECTIVES: Subjective sleep complaints have been reported in up to 80% of patients with end stage renal disease (ESRD). In these patients, sleep disturbances manifesting as insomnia, sleep apnea syndrome, restless leg syndrome (RLS), periodic limb movement disorder and excessive daytime sleepiness (EDS) have been frequently reported. Moreover, studies about the role of dialysis shift on sleep abnormalities, mo...
Sleep disturbances and prevalence of depression in systemic lupus erythematosus...
Mesquita,Rafael Carvalho; Souza,Lívia Noronha Coelho de; Bruin,Pedro Felipe Carvalhedo de; Carvalho,Raquel Ribeiro; Medeiros,Marta Maria das ChagasBACKGROUND: Pulse i.v. cyclophosphamide is a therapeutic option in severe forms of systemic lupus erythematosus (SLE). However, the overall toxicity and risk profile are yet to be adequately defined. OBJECTIVE: To evaluate the occurrence of sleep disturbances in SLE patients subjected to i.v. cyclophosphamide. METHODS: We studied thirty consecutive SLE patients (27 female) age range 14 to 53 years (mean 30.5 ± ...